title: Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. I. Substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitro.
abstract: The ability of substance P (SP) to regulate peak benzyl-penicilloyl (BPO)-specific IgE antibody-forming cell (AFC) responses in vivo and the ability of SP and other neuropeptides to regulate BPO-specific memory IgE AFC responses induced in vitro was determined. SP injected subcutaneously into BPO-keyhole limpet hemocyanin (BPO-KLH)-sensitized mice at the time of peak IgE responses suppressed these responses within 48 h (> 90%). The suppression obtained was IgE isotype-specific, dose-dependent, and transient. When spleen cells from immunized mice were cultured for 5 days with BPO-KLH, peak memory IgE AFC responses were induced in vitro. Inclusion of either SP or vasoactive intestinal peptide (VIP), but not neurotensin, serotonin, somatostatin, or gastrin, in cultures suppressed these responses in isotype-specific, dose-dependent fashion (approximately 70%). SP-, but not VIP-mediated suppression of IgE responses was abrogated by inclusion of anti-IFN gamma culture.
authors.affiliation: Department of Pathology, State University of New York-Health Science Center at Brooklyn 11203.
authors.forename: J A
authors.initials: JA
authors.lastname: Carucci
authors.forename: D L
authors.initials: DL
authors.lastname: Auci
authors.forename: C A
authors.initials: CA
authors.lastname: Herrick
authors.forename: H G
authors.initials: HG
authors.lastname: Durkin
mesh_terms: D000818:Animals; D044482:Benzeneacetamides; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005260:Female; D005755:Gastrins / Q000494:pharmacology; D006241:Haptens / Q000032:analysis*; D007073:Immunoglobulin E / Q000032:analysis / Q000096:biosynthesis*; D007371:Interferon-gamma / Q000502:physiology; D008297:Male; D051379:Mice; D009479:Neuropeptides / Q000494:pharmacology*; D009496:Neurotensin / Q000494:pharmacology; D010400:Penicillin G / Q000031:analogs & derivatives / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013004:Somatostatin / Q000494:pharmacology; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D013373:Substance P / Q000494:pharmacology*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
chemical_list: D044482:Benzeneacetamides; D005755:Gastrins; D006241:Haptens; D009479:Neuropeptides; C015026:benzylpenicilloyl G; D012701:Serotonin; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D007073:Immunoglobulin E; D009496:Neurotensin; D013004:Somatostatin; D007371:Interferon-gamma; D010400:Penicillin G